|
|
Effect of Huaier Granule Combined with Neoadjuvant Chemotherapy for Breast Cancer and Its Influence on P53 Ki-67 MMP-2 and MMP-9 Levels |
SHAN Changyou, DIAO Yan, HUANG Shan, et al |
The Second Affiliated Hospital of Xi'an Jiaotong University, Shaanxi Xi'an 710004, China |
|
|
Abstract Objective: To study the curative efficacy of huaier granule combined with neoadjuvant chemotherapy on the breast cancer and the serum levels of P53 gene(P53), Ki-67 antigen(Ki-67), matrix metalloproteinase (MMP)-2 and matrix metalloproteinase (MMP-9). Methods: 92 patients with breast cancer admitted in our hospital from March 2011 to March 2013 were selected and randomly divided into the observation group (n=46) and the control group (n=46). The patients in control group were treated with neoadjuvant chemotherapy (pirarubicin+paclitaxel intravenous injection), while the patients in observation group were treated with huaier granule. Then the positive expression rate of P53 and Ki-67, changes of MMP-2 and MMP-9, clinical efficacy, survival rate and complications in the two groups were observed and compared before and after treatment. Results: After treatment, the positive expression rate of P53 in the observation group was significantly increased, and the positive rate of Ki-67 was significantly decreased (P<0.05), the serum levels of MMP-2 and MMP-9 of both groups were significantly lower than those before treatment and the MMP-2 and MMP-9 in the observation group were significantly lower than those of the control group (P<0.05). The clinical efficacy of observation group was significantly higher than that of the control group (P<0.05). The incidence rate of gastrointestinal reaction, myelosuppression, alopecia and liver function injury of observation group was significantly lower than that of the control group (P<0.05);during the follow-up period, 4 cases were lost in the observation group and 5 cases were lost in the control group,the survival rate in the observation group in 3 years was significantly higher than that of the control group. (P<0.05). Conclusion: Huaier granule combined with neoadjuvant chemotherapy had better clinical efficacy on breast cancer, which could effectively reduce the side effects and improve the prognosis, its may be closely related to the regulation of P53, Ki67, MMP-2, and MMP-9 levels.
|
|
|
|
|
[1] 刘海鸥,张喜平.乳腺癌新辅助化疗的研究进展[J].医学综述,2014,20(4):653~656. [2] 吕民豪,秦丽,李军涛,等.原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J].肿瘤防治研究,2015,42(8):782~788. [3] 雷建勇,严律南,曾勇,等.槐耳颗粒与索拉菲尼对于小肝癌切除术后的有效性及安全性分析[J].中国普外基础与临床杂志,2014,21(8):991~995. [4] 雷姗姗,王映,顾晓文,等.槐耳颗粒在三阴性乳腺癌术后辅助治疗的临床研究[J].中国普通外科杂志,2016,25(5):717~723. [5] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2015版)[J].中国癌症杂志,2015,25(9):692~754. [6] 孙艺宁,张蓓,张姗,等.槐耳颗粒免疫调控CXCL1在乳腺癌中的作用研究[J].免疫学杂志,2016,32(6):507~512. [7] 华向东,尚海,何忠野,等.槐耳颗粒联合经导管肝动脉化疗栓塞在原发性肝癌伴微血管侵犯根治术后的疗效分析[J].中国普外基础与临床杂志,2016,23(8):982~986. [8] 梁月琴,尹文洁,钱文,等.槐耳颗粒联合全身化疗对晚期乳腺癌患者免疫功能及预后的影响[J].中国普外基础与临床杂志,2015,22(12):1482~1486. [9] 黄榕权,谢燕清,张雅洁.乳腺癌MMP-2、MMP-9的体外阻断研究[J].现代肿瘤医学,2014,22(5):1049~1053. [10] 黄榕权,谢燕清,张雅洁.MMP-2、MMP-9和VEGF-D在乳腺癌中的表达及其与肿瘤淋巴管新生的关系[J].广东医学,2014,35(13):2072~2074. |
|
|
|